Medsafe: New Zealand Medicines and Medical Devices Safety Authority

MEDSAFE


New Zealand Medicines and Medical
Devices Safety Authority

Revised: 26 August 2026

Medicines

 

Medsafe Product Detail

File ref: TT50-4804/1
Trade Name Dose Form Strength Identifier
Peditrace Solution for infusion .
Sponsor Application date Regulatory status Classification
Fresenius Kabi New Zealand Limited
c/o GNZCC
HSBC Tower, Level 14
188 Quay Street
Auckland 1010
12/05/1995 Approval lapsed
Approval date:21/06/1995
Notification date: 5/08/2021
General sale

Composition

Component Ingredient Manufacturer
solution for infusionActive 
 Copper chloride dihydrate 53.7 µg/mL equivalent to 20 µg/0.315 µmol Cu/mLMerck KGaA
Frankfurter Strasse 250
Darmstadt 64293
GERMANY
 Manganese chloride tetrahydrate 3.6 µg/mL (Tetrahydrate, =1µg/18.2nmol Mn/mL)Merck KGaA
Frankfurter Strasse 250
Darmstadt 64293
GERMANY
 Potassium iodide 1.31 µg/mL equivalent to 1 µg/7.88 nmol I/mLMerck KGaA
Frankfurter Strasse 250
Darmstadt 64293
GERMANY
 Sodium fluoride 126 µg/mL equivalent to 57 µg/3.0 µmol F/mLMerck KGaA
Frankfurter Strasse 250
Darmstadt 64293
GERMANY
 Sodium selenite 4.38 µg/mL (Anhydrous =2µg/25.3nmol Se/mL)Retorte GmbH Selenium Chemicals & Metals
Sulzbacher Strasse 45
Rothenbach D-90552
GERMANY
 Zinc chloride 521 µg/mL equivalent to 250 µg/3.82 µmol Zn/mLMerck KGaA
Frankfurter Strasse 250
Darmstadt 64293
GERMANY
 Excipient 
 Hydrochloric acid
 Water for injection

Production

Manufacturing step Manufacturer
Manufacture of Active IngredientMerck KGaA
Frankfurter Strasse 250
Darmstadt 64293
GERMANY
 Merck KGaA
Frankfurter Strasse 250
Darmstadt 64293
GERMANY
 Merck KGaA
Frankfurter Strasse 250
Darmstadt 64293
GERMANY
 Merck KGaA
Frankfurter Strasse 250
Darmstadt 64293
GERMANY
 Merck KGaA
Frankfurter Strasse 250
Darmstadt 64293
GERMANY
 Retorte GmbH Selenium Chemicals & Metals
Sulzbacher Strasse 45
Rothenbach D-90552
GERMANY
Manufacture of Final Dose FormFresenius Kabi Norge AS
Svinesundveien 80
Halden NO-1788
NORWAY
PackingFresenius Kabi Norge AS
Svinesundveien 80
Halden NO-1788
NORWAY
Secondary PackagingPharmaco (NZ) Ltd
4 Fisher Crescent
Mt Wellington
AUCKLAND 1060
NZ Site of Product ReleasePharmacy Retailing (NZ) Ltd t/a Healthcare Logistics
58 Richard Pearse Drive
Airport Oaks
Mangere
AUCKLAND 2022

Packaging

Package Contents Shelf life
Vial, plastic, 10 x 10mL100 mL36 months from date of manufacture stored at or below 25°C

Indications

Peditrace is indicated in premature and full-term infants and children needing intravenous nutrition to supply the basal requirements of trace elements.

Latest Regulatory Activity

Application DateApplication TypeChange(s)StatusPayment DatePriority
1/10/2015Changed Medicine NotificationActive ingredient manufacturing process - Grade 3; Administrative fee (CMN)Granted9/10/2015